| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |